|
|||
October 2, 2004Abilify approved for Bipolar Disorder Maniafiled under Bipolar Disorder Complimentary Treatments
Bristol-Myers Squibb (bmy) and partner Otsuka Pharmaceutical received approval of Abilify, a drug for the treatment of acute bipolar mania, from the Food and Drug Administration. Abilify was previously approved in 2002 by the FDA to treat schizophrenia. Posted by szadmin at October 2, 2004 8:02 AM
More Information on Bipolar Disorder Complimentary Treatments CommentsPost a comment |
ADVERTISEMENT
|